Computational toxicology: an overview of the sources of data and of modelling methods

Bibliography

• Balbus JM. Ushering in the new toxicology: Toxicogenomics and the public interest. Environ Health Perspect 2005;113:818-22
   PubMed Web of Science ®Google Scholar
• Richard AM. Future of toxicology–predictive toxicology: An expanded view of “chemical toxicity”. Chem Res Toxicol 2006;19:1257-62
   PubMed Web of Science ®Google Scholar
• Azzaoui K, Hamon J, Faller B, et al. Modeling promiscuity based on in vitro safety pharmacology profiling data. ChemMedChem 2007;2:874-80
   PubMed Web of Science ®Google Scholar
• Matthews EJ, Benz RD, Contrera JF. Use of toxicological information in drug design. J Mol Graph Mod 2000;18:605-15
   PubMed Web of Science ®Google Scholar
• Selick HE, Beresford AP, Tarbit MH. The emerging importance of predictive ADME simulation in drug discovery. Drug Discov Today 2002;7:109-16
   PubMed Web of Science ®Google Scholar
• Mendrick DL. Genomic and genetic biomarkers of toxicity. Toxicology 2008;245:175-81
   PubMed Web of Science ®Google Scholar
• Moore TJ, Cohen MR, Furberg CD. Serious adverse drug events reported to the food and drug administration, 1998-2005. Arch Intern Med 2007;167:1752-9
   PubMed Web of Science ®Google Scholar
• Suter W. Predictive value of in vitro safety studies. Curr Opin Chem Biol 2006;10:362-6
   PubMed Web of Science ®Google Scholar
• Waters M, Boorman G, Bushel P, et al. Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base. EHP Toxicogenomics 2003;111:15-28
   PubMedGoogle Scholar
• Waters MD, Fostel JM. Toxicogenomics and systems toxicology: aims and prospects. Nat Rev Genet 2004;5:936-48
   PubMed Web of Science ®Google Scholar
• Castle AL, Carver MP, Mendrick DL. Toxicogenomics: a new revolution in drug safety. Drug Discov Today 2002;7:728-36
   PubMed Web of Science ®Google Scholar
• Benz RD. Toxicological and clinical computational analysis and the USFDA/CDER. Expert Opin Drug Metab Toxicol 2007;3:109-24
   PubMed Web of Science ®Google Scholar
• Richard AM, Yang C, Judson RS. Toxicity data informatics: Supporting a new paradigm for toxicity prediction. Toxicol Mech Method 2008;18:103-18
   PubMed Web of Science ®Google Scholar
• Registration, Evaluation, Authorisation and Restriction of Chemical substances – Available from: http://ec.europa.eu/environment/chemicals/reach/reach_intro.htm
   Google Scholar
• Richard AM, Gold LS, Nicklaus MC. Chemical structure indexing of toxicity data on the internet: moving toward a flat world. Curr Opin Drug Discov Devel 2006;9:314-25
   PubMed Web of Science ®Google Scholar
• Liu B, Li S, Hu J. Technological advances in high-throughput screening. Am J Pharmacogenomics 2004;4:263-76
   PubMedGoogle Scholar
• Young DW, Bender A, Hoyt J, et al. Integrating high-content screening and ligand-target prediction to identify mechanism of action. Nat Chem Biol 2008;4:59-68
   PubMed Web of Science ®Google Scholar
• Adriaens ME, Jaillard M, Waagmeester A, et al. The public road to high-quality curated biological pathways. Drug Discov Today 2008;13:856-62
   PubMed Web of Science ®Google Scholar
• Barabasi A, Oltvai Z. Network biology: understanding the cell's functional organization. Nat Rev Genet 2004;5:101-13
   PubMed Web of Science ®Google Scholar
• Bundy J, Sidhu J, Rana F, et al. ‘Systems toxicology’ approach identifies coordinated metabolic responses to copper in a terrestrial non-model invertebrate, the earthworm Lumbricus rubellus. BMC Biol 2008;6:25
   PubMedGoogle Scholar
• Ekins S, Andreyev S, Ryabov A, et al. A combined approach to drug metabolism and toxicity assessment. Drug Metab Dispos 2006;34:495-503
   PubMed Web of Science ®Google Scholar
• Jalaie M, Holsworth DD. QT interval prolongation: and the beat goes on. Mini Rev Med Chem 2005;5:1083-91
   PubMed Web of Science ®Google Scholar
• Kerns E, Di L. Pharmaceutical profiling in drug discovery. Drug Discov Today 2003;8:316-23
   PubMed Web of Science ®Google Scholar
• Bajorath J. Integration of virtual and high-throughput screening. Nat Rev Drug Discov 2002;1:882-94
   PubMed Web of Science ®Google Scholar
• Giuliano KA, Johnston PA, Gough A, Taylor DL. Systems cell biology based on high-content screening. Methods Enzymol 2006;414:601-19
   PubMed Web of Science ®Google Scholar
• Li AP. Human hepatocytes: isolation, cryopreservation and applications in drug development. Chem Biol Interact 2007;168:16-29
   PubMed Web of Science ®Google Scholar
• Li AP. In vitro evaluation of human xenobiotic toxicity: scientific concepts and the novel integrated discrete multiple cell co-culture (IdMOC) technology. ALTEX: Alternativen zu Tierexperimenten 2008;25:43-9
   PubMed Web of Science ®Google Scholar
• Parng C, Roy NM, Ton C, et al. Neurotoxicity assessment using zebrafish. J Pharmacol Toxicol Methods 2007;55:103-12
   PubMedGoogle Scholar
• Spicker J, Pedersen H, Nielsen H, Brunak S. Analysis of cell death inducing compounds. Arch Toxicol 2007;81:803-11
   PubMed Web of Science ®Google Scholar
• Xing JZ, Zhu L, Gabos S, Xie L. Microelectronic cell sensor assay for detection of cytotoxicity and prediction of acute toxicity. Toxicology in vitro: an international journal published in association with BIBRA 2006;20:995-1004
   Google Scholar
• Macgregor JT, Casciano D, Müller L. Strategies and testing methods for identifying mutagenic risks. Mutat Res 2000;455:3-20
   PubMed Web of Science ®Google Scholar
• Eisenbrand G, Pool-Zobel B, Baker V, et al. Methods of in vitro toxicology. Food Chem Toxicol 2002;40:193-236
   PubMed Web of Science ®Google Scholar
• Nicholson RL, Welch M, Ladlow M, Spring DR. Small-molecule screening: advances in microarraying and cell-imaging technologies. ACS Chem Biol 2007;2:24-30
   PubMed Web of Science ®Google Scholar
• Oberemm A, Onyon L, Gundert-Remy U. How can toxicogenomics inform risk assessment? Toxicol Appl Pharmacol 2005;207:592-98
   PubMedGoogle Scholar
• Suter L, Babiss LE, Wheeldon EB. Toxicogenomics in predictive toxicology in drug development. Chem Biol 2004;11:161-71
   PubMed Web of Science ®Google Scholar
• Mattes WB, Pettit SD, Sansone S, et al. Database development in toxicogenomics: issues and efforts. Environ Health Perspect 2004;112:495-505
   PubMed Web of Science ®Google Scholar
• Suter L, Babiss LE, Wheeldon EB. Toxicogenomics in predictive toxicology in drug development. Chem Biol 2004;11:161-71
   PubMed Web of Science ®Google Scholar
• Heijne WHM, Kienhuis AS, Van Ommen B, et al. Systems toxicology: applications of toxicogenomics,transcriptomics, proteomics and metabolomics in toxicology. Expert Rev Proteomics 2005;2:767-80
   PubMed Web of Science ®Google Scholar
• Borgert CJ. Predicting interactions from mechanistic information: Can omic data validate theories? Toxicol Appl Pharmacol 2007;223:114-20
   PubMed Web of Science ®Google Scholar
• Gunther EC, Stone DJ, Gerwien RW, et al. Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro. Proc Natl Acad Sci USA 2003;100:9608-13
   PubMed Web of Science ®Google Scholar
• Lord PG. Progress in applying genomics in drug development. Toxicol Lett 2004;149:371-5
   PubMed Web of Science ®Google Scholar
• Tong W, Cao X, Harris S, et al. ArrayTrack: supporting toxicogenomic research at the US Food and Drug Administration National Center for Toxicological Research. Environ Health Perspect 2003;111:1819-26
   PubMed Web of Science ®Google Scholar
• Tong W, Harris S, Cao X, et al. Development of public toxicogenomics software for microarray data management and analysis. Mutat Res 2004;549:241-53
   PubMed Web of Science ®Google Scholar
• Bushel P, Wolfinger R, Gibson G. Simultaneous clustering of gene expression data with clinical chemistry and pathological evaluations reveals phenotypic prototypes. BMC Syst Biol 2007;1:15
   PubMedGoogle Scholar
• Fliri AF, Loging WT, Volkmann RA. Analysis of system structure-function relationships. ChemMedChem 2007;2:1774-82
   PubMed Web of Science ®Google Scholar
• Waters M, Stasiewicz S, Merrick BA, et al. CEBS–Chemical Effects in Biological Systems: a public data repository integrating study design and toxicity data with microarray and proteomics data. Nucleic Acids Res 2008;36:D892-900
   Web of Science ®Google Scholar
• Johnson DE, Rodgers AD. Computational toxicology: heading toward more relevance in drug discovery and development. Curr Opin Drug Discov Devel 2006;9:29-37
   PubMed Web of Science ®Google Scholar
• Yang C, Benz RD, Cheeseman MA. Landscape of current toxicity databases and database standards. Curr Opin Drug Discov Devel 2006;9:124-33
   PubMed Web of Science ®Google Scholar
• Yang C, Hasselgren C, Boyer S, et al. Understanding genetic toxicity through data mining: The process of building knowledge by integrating multiple genetic toxicity databases. Toxicol Mech Method 2008;18:277-95
   PubMed Web of Science ®Google Scholar
• Richard AM, Williams CR. Distributed structure-searchable toxicity (DSSTox) public database network: a proposal. Mutat Res 2002;499:27-52
   PubMed Web of Science ®Google Scholar
• Waters KM, Pounds JG, Thrall BD. Data merging for integrated microarray and proteomic analysis. Brief Funct Genomic Proteomic 2006;5:261-72
   PubMedGoogle Scholar
• Von Korff M, Sander T.Toxicity-indicating structural patterns. J Chem Inf Model 2006;46:536-44
   PubMed Web of Science ®Google Scholar
• Foggia P, Limongiello A, Tufano F, Vento M. Learning graphs from examples: An application to the prediction of the toxicity of chemical compounds. Int J Pattern Recog Artif Intell 2006;20:883-96
   Web of Science ®Google Scholar
• Kho R, Hodges JA, Hansen MR, Villar HO. Ring Systems in Mutagenicity Databases. J Med Chem 2005;48:6671-8
   PubMed Web of Science ®Google Scholar
• Llorens O, Perez J, Villar HO. Investigation of structural and electronic biases in mutagenic compounds. Int J Quant Chem 2002;88:107-17
   Web of Science ®Google Scholar
• Simon-Hettich B, Rothfuss A, Steger-Hartmann T. Use of computer-assisted prediction of toxic effects of chemical substances. Toxicology 2006;224:156-62
   PubMed Web of Science ®Google Scholar
• Benigni R, Netzeva TI, Benfenati E, et al. The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2007;25:53-97
   PubMed Web of Science ®Google Scholar
• Muster W, Breidenbach A, Fischer H, et al. Computational toxicology in drug development. Drug Discov Today 2008;13:303-10
   PubMed Web of Science ®Google Scholar
• Kruhlak NL, Contrera JF, Benz RD, Matthews EJ. Progress in QSAR toxicity screening of pharmaceutical impurities and other FDA regulated products. Adv Drug Deliv Rev 2007;59:43-55
   PubMed Web of Science ®Google Scholar
• Knize MG, Hatch FT, Tanga MJ, et al. A QSAR for the mutagenic potencies of twelve 2-amino-trimethylimidazopyridine isomers: structural, quantum chemical, and hydropathic factors. Environ Mol Mutagen 2006;47:132-46
   PubMed Web of Science ®Google Scholar
• Matthews EJ, Kruhlak NL, Benz RD, et al. Combined use of MC4PC, MDL-QSAR, BioEpisteme, leadscope PDM, and derek for windows software to achieve high-performance, high-confidence, mode of action-based predictions of chemical carcinogenesis in rodents. Toxicol Mech Method 2008;18:189-206
   PubMed Web of Science ®Google Scholar
• Bhavani S, Nagargadde A, Thawani A, et al. Substructure-based support vector machine classifiers for prediction of adverse effects in diverse classes of drugs. J Chem Inf Model 2006;46:2478-86
   PubMed Web of Science ®Google Scholar
• Whitebread S, Hamon J, Bojanic D, Urban L. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development. Drug Discov Today 2005;10:1421-33
   PubMed Web of Science ®Google Scholar
• Vedani A, Descloux AV, Spreafico M, Ernst B. Predicting the toxic potential of drugs and chemicals in silico: a model for the peroxisome proliferator-activated receptor gamma (PPAR gamma). Toxicol Lett 2007;173:17-23
   PubMed Web of Science ®Google Scholar
• Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999;20:649-88
   PubMed Web of Science ®Google Scholar
• Peraza MA, Burdick AD, Marin HE, et al. The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). Toxicol Sci 2006;90:269-95
   PubMed Web of Science ®Google Scholar
• Nigsch F, Mitchell JBO. Toxicological relationships between proteins obtained from protein target predictions of large toxicity databases. Toxicol Appl Pharmacol 2008;231:225-34
   PubMed Web of Science ®Google Scholar
• Nigsch F, Bender A, Jenkins JL, Mitchell JBO. Ligand-Target Prediction using Winnow and Naïve Bayesian Algorithms and the Implications of Overall Performance Statistics. J Chem Inf Model 2008; accepted
   Google Scholar
• Bender A, Scheiber J, Glick M, et al. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure. ChemMedChem 2007;2:861-73
   PubMed Web of Science ®Google Scholar
• Scripture CD, Figg WD. Drug interactions in cancer therapy. Nat Rev Cancer 2006;6:546-58
   PubMed Web of Science ®Google Scholar
• Hopkins AL, Mason JS, Overington JP. Can we rationally design promiscuous drugs? Curr Opin Struct Biol 2006;16:127-36
   PubMed Web of Science ®Google Scholar
• Wermuth CG. Selective optimization of side activities: another way for drug discovery. J Med Chem 2004;47:1303-14
   PubMed Web of Science ®Google Scholar
• Nettles JH, Jenkins JL, Bender A, et al. Bridging chemical and biological space: “target fishing” using 2D and 3D molecular descriptors. J Med Chem 2006;49:6802-10
   PubMed Web of Science ®Google Scholar
• Lagunin A, Stepanchikova A, Filimonov D, Poroikov V. PASS: prediction of activity spectra for biologically active substances. Bioinformatics 2000;16:747-8
   PubMed Web of Science ®Google Scholar
• Olah M, Mracec M, Ostopovici L, et al. WOMBAT: World of Molecular Bioactivity. In Chemoinformatics in Drug Discovery; Oprea, T. I., Ed.; Wiley-VCH: New York, 2004:223-39
   Google Scholar
• Symyx, 2440 Camino Ramon, Suite 300, San Ramon, CA 94583
   Google Scholar
• Inpharmatica Ltd, 60 Charlotte St., London W1T 2NU, UK
   Google Scholar
• CEREP, 155 Boulevard Haussmann, 75008 Paris, France
   Google Scholar
• Gunther S, Kuhn M, Dunkel M, et al. SuperTarget and Matador: resources for exploring drug-target relationships. Nucleic Acids Res 2008;36:D919-22
   PubMed Web of Science ®Google Scholar
• Kuhn M, Von Mering C, Campillos M, et al. STITCH: interaction networks of chemicals and proteins. Nucleic Acids Res 2008;36:D684-688
   PubMed Web of Science ®Google Scholar
• Li H, Zhang H, Liu X, et al. PDTD: a web-accessible protein database for drug target identification. BMC Bioinformatics 2008;9:104
   PubMedGoogle Scholar
• Wishart DS, Knox C, Guo AC, et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 2008;36:D901-6
   PubMed Web of Science ®Google Scholar
• Ji ZL, Han LY, Yap CW, et al. Drug Adverse Reaction Target Database (DART) : proteins related to adverse drug reactions. Drug Saf 2003;26:685-90
   PubMed Web of Science ®Google Scholar
• Rokosz LL, Beasley JR, Carroll CD, et al. Kinase inhibitors as drugs for chronic inflammatory and immunological diseases: progress and challenges. Expert Opin Ther Targets 2008;12:883-903
   PubMed Web of Science ®Google Scholar
• Prediction of Activity Spectra for Substances – http://195.178.207.233/PASS/index.html
   Google Scholar
• Nigsch F, Mitchell JBO. Toxicological relationships between proteins obtained from protein target predictions of large toxicity databases. Toxicol Appl Pharmacol 2008;231:225-34
   PubMed Web of Science ®Google Scholar
• Glick M, Davies JW, Jenkins JL. Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases. J Chem Inf Model 2006;46:1124-33
   PubMed Web of Science ®Google Scholar
• Rogers D, Brown RD, Hahn M. Using extended-connectivity fingerprints with Laplacian-modified Bayesian analysis in high-throughput screening follow-up. J Biomol Screen 2005;10:682-6
   PubMed Web of Science ®Google Scholar
• Jenkins JL, Glick M, Davies JW. A 3D Similarity Method for Scaffold Hopping from Known Drugs or Natural Ligands to New Chemotypes. J Med Chem 2004;47:6144-59
   PubMed Web of Science ®Google Scholar
• Zauhar RJ, Moyna G, Tian L, et al. Shape signatures: a new approach to computer-aided ligand-and receptor-based drug design. J Med Chem 2003;46:5674-90
   PubMed Web of Science ®Google Scholar
• Chekmarev DS, Kholodovych V, Balakin KV, et al. Shape signatures: new descriptors for predicting cardiotoxicity in silico. Chem Res Toxicol 2008;21:1304-14
   PubMed Web of Science ®Google Scholar
• Keiser MJ, Roth BL, Armbruster BN, et al. Relating protein pharmacology by ligand chemistry. Nat Biotechnol 2007;25:197-206
   PubMed Web of Science ®Google Scholar
• Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there? Nat Rev Drug Discov 2006;5:993-6
   PubMed Web of Science ®Google Scholar
• Hopkins AL, Groom CR. The druggable genome. Nature Rev Drug Discov 2002;1:727-30
   PubMed Web of Science ®Google Scholar
• Schlyer S, Horuk R. I want a new drug: G-protein-coupled receptors in drug development. Drug Discov Today 2006;11:481-93
   PubMed Web of Science ®Google Scholar
• Costanzi S. On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor. J Med Chem 2008;51:2907-14
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhi D. Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule. Proteins 2001;43:217-26
   PubMed Web of Science ®Google Scholar
• Available from: http://195.178.207.233/PASS/index.html
   Google Scholar
• Gold ND, Jackson RM. Fold independent structural comparisons of protein-ligand binding sites for exploring functional relationships. J Mol Biol 2006;355:1112-24
   PubMed Web of Science ®Google Scholar
• Gold ND, Jackson RM. SitesBase: a database for structure-based protein-ligand binding site comparisons. Nucleic Acids Res 2006;34:D231-4
   Google Scholar
• Gold ND, Jackson RM. A searchable database for comparing protein-ligand binding sites for the analysis of structure-function relationships. J Chem Inf Model 2006;46:736-42
   PubMed Web of Science ®Google Scholar
• Brakoulias A, Jackson RM. Towards a structural classification of phosphate binding sites in protein-nucleotide complexes: an automated all-against-all structural comparison using geometric matching. Proteins 2004;56:250-60
   PubMed Web of Science ®Google Scholar
• Kuhn D, Weskamp N, Hüllermeier E, Klebe G. Functional classification of protein kinase binding sites using Cavbase. ChemMedChem 2007;2:1432-47
   PubMed Web of Science ®Google Scholar
• Kellenberger E, Schalon C, Rognan D. How to measure the similarity between protein ligand-binding sites? Curr Comput Aided Drug Des 2008;4:209-20
   Web of Science ®Google Scholar
• Lai L. Prediction of potential drug targets based on simple sequence properties. BMC Bioinformatics 2007;8:353
   PubMedGoogle Scholar
• Bender A, Young DW, Jenkins JL, et al. Chemogenomic data analysis: prediction of small-molecule targets and the advent of biological fingerprint. Comb Chem High Throughput Screen 2007;10:719-31
   PubMed Web of Science ®Google Scholar
• Lapinsh M, Prusis P, Gutcaits A, et al. Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions. Biochim Biophys Acta 2001;1525:180-90
   PubMed Web of Science ®Google Scholar
• Strombergsson H, Kryshtafovych A, Prusis P, et al. Generalized modeling of enzyme-ligand interactions using proteochemometrics and local protein substructures. Proteins 2006;65:568-79
   PubMed Web of Science ®Google Scholar
• Strombergsson H, Prusis P, Midelfart H, et al. Rough set-based proteochemometrics modeling of G-protein-coupled receptor-ligand interactions. Proteins 2006;63:24-34
   PubMed Web of Science ®Google Scholar
• Greene N. Computer systems for the prediction of toxicity: an update. Adv Drug Deliv Rev 2002;54:417-31
   PubMed Web of Science ®Google Scholar
• Contrera JF, Kruhlak NL, Matthews EJ, Benz RD. Comparison of MC4PC and MDL-QSAR rodent carcinogenicity predictions and the enhancement of predictive performance by combining QSAR models. Regul Toxicol Pharmacol 2007;49:172-82
   PubMed Web of Science ®Google Scholar
• Marchant CA, Briggs KA, Long A. In silico tools for sharing data and knowledge on toxicity and metabolism: Derek for windows, meteor, and vitic. Toxicol Mech Method 2008;18:177-87
   PubMed Web of Science ®Google Scholar
• Hall LH, Kier LB. The E-state as the basis for molecular structure space definition and structure similarity. J Chem Inf Comput Sci 2000;40:784-91
   PubMedGoogle Scholar